Literature DB >> 20491082

Chemopreventive properties of phytosterols and maslinic acid extracted from Coleus tuberosus in inhibiting the expression of EBV early-antigen in Raji cells.

Lim Yang Mooi1, Norhanom Abdul Wahab, Nordin Haji Lajis, Abdul Manaf Ali.   

Abstract

Bioassay-guided fractionation of a MeOH extract of tubers of Coleus tuberosus afforded the active anti-tumor-promoting compounds identified as the triterpenoid 2alpha,3beta-dihydroxyolean-12-en-28-oic acid (maslinic acid; CT2) and a phytosterol mixture (CT1). CT1 consists of stigmasterol (32%), beta-sitosterol (40.3%), and campesterol (27.7%) as determined by capillary gas chromatography. CT1 and CT2 showed very strong anti-tumor-promoting activities at IC(50) 0.7 microg/ml and 0.1 microg/ml, respectively, in a convenient, short-term in vitro assay, i.e., the inhibition of Epstein-Barr virus (EBV) activation induced by phorbol 12-myristate 13-acetate (PMA) and sodium butyrate. We report for the first time the anti-tumor-promoting activity of 2alpha,3beta-dihydroxyolean-12-en-28-oic acid and show that a mixture of stigmasterol, beta-sitosterol, and campesterol is more potent than the individual components in inhibiting tumor-promoting activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20491082     DOI: 10.1002/cbdv.200900193

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  2 in total

1.  Noncytotoxic and Antitumour-Promoting Activities of Garcinia Acid Esters from Garcinia atroviridis Griff. ex T. Anders (Guttiferae).

Authors:  Mukram M Mackeen; Lim Y Mooi; Mohidin Amran; Nashriyah Mat; Nordin H Lajis; Abdul M Ali
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-28       Impact factor: 2.629

2.  Cytotoxicity, Antiproliferative Effects, and Apoptosis Induction of Methanolic Extract of Cynometra cauliflora Linn. Whole Fruit on Human Promyelocytic Leukemia HL-60 Cells.

Authors:  T-Johari S A Tajudin; Nashriyah Mat; Abu Bakar Siti-Aishah; A Aziz M Yusran; Afnani Alwi; Abdul Manaf Ali
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-04       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.